Merck & Co., Inc. Deferred Income Taxes and Other Assets, Current
Merck & Co., Inc. (MRK) had Deferred Income Taxes and Other Assets, Current of $6.64 billion as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Notes › Deferred Income Taxes and Other Assets
us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent · last filed 2023-08-07
- 2023-06-30: Deferred Income Taxes and Other Assets, Current $6.64B.
- 2023-03-31: Deferred Income Taxes and Other Assets, Current $6.74B.
- 2022-12-31: Deferred Income Taxes and Other Assets, Current $7.17B.
- 2022-09-30: Deferred Income Taxes and Other Assets, Current $7.22B.
| Period end | Deferred Income Taxes and Other Assets, Current | Deferred Income Taxes and Other Assets, Current as first filed |
|---|---|---|
| 2023-06-30 | $6.64B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $6.74B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $7.17B 10-Q · filed 2023-08-07 | |
| 2022-09-30 | $7.22B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $6.81B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $6.65B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $6.99B 10-Q · filed 2022-11-03 | |
| 2021-09-30 | $6.87B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $6.75B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $5.29B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $4.67B 10-Q · filed 2021-11-05 | $5.54B 10-Q · filed 2021-05-05 |
| 2020-09-30 | $4.67B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.61B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $4.71B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $4.28B 10-Q · filed 2020-11-05 | |
| 2019-09-30 | $3.83B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.38B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.23B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $4.50B 10-Q · filed 2019-11-05 | |
| 2018-09-30 | $3.76B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $4.00B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $4.11B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $4.30B 10-Q · filed 2018-11-06 | |
| 2017-09-30 | $3.79B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $3.35B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $4.07B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.39B 10-Q · filed 2017-11-07 | |
| 2016-09-30 | $3.77B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $3.93B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $3.88B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $5.14B 10-Q · filed 2016-11-07 | |
| 2015-09-30 | $4.94B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $5.13B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.12B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $5.26B 10-Q · filed 2015-11-05 | |
| 2014-09-30 | $4.74B 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $3.66B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.94B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.79B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $5.28B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $4.35B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $4.48B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $4.51B 10-K · filed 2014-02-27 | |
| 2012-09-30 | $3.43B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $3.79B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $3.71B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $3.69B 10-K · filed 2013-02-28 | |
| 2011-09-30 | $4.16B 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $3.69B 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $3.65B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |